Estrogen treatment induces MLL aberrations in human lymphoblastoid cells
β Scribed by Sabine Schnyder; Nga T. Du; Hongan B. Le; Sheetal Singh; Grace A. Loredo; Andrew T. Vaughan
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 293 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Morphological aspects of cell death associated with a cytolethal concentration of methylprednisolone sodium succinate (500 micrograms/ml) on the BLA1 lymphoblastoid cell line were studied over a 48-hr incubation period by light, transmission and scanning electron microscopy. Studies revealed two dis
## Abstract Redistribution and consequent cap formation of EpsteinβBarr virus adsorbed to human lymphoblastoid cells were studied by indirect membrane immunofluorescence carried out at 0Β° C. When EBV was adsorbed on cells at 0Β° C, the cell sur face fluorescence had a mostly ringβlike pattern. Howev
## Abstract Estrogens are important etiologic agents for most gynecologic malignancies, and chronic exposure to estrogen that is unopposed by progestins conveys the greatest risk. Treatments with estrogen facilitate the process of malignant transformation in rodents, but relatively few studies of e
We examined the effects of acivicin, a specific inhibitor of the ectoenzyme y-glutamyltransferase (y-GT), on y-GT activity and apoptosis in 2 human T-lymphoblastoid CEM cell lines, CCRF and VBL-100. In both cell lines, acivicin was found to cause morphological and biochemical changes of apoptosis in